Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)
Public ClinicalTrials.gov record NCT01964352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to assess the efficacy and safety of 12 weeks once daily treatment with orally inhaled tiotropium + olodaterol FDC (delivered by the Respimat inhaler) compared with tiotropium and placebo in patients with COPD.
Study identification
- NCT ID
- NCT01964352
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 813 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2013
- Primary completion
- Sep 30, 2014
- Completion
- Oct 31, 2014
- Last update posted
- Nov 24, 2015
2013 – 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1237.25.10504 Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| 1237.25.10507 Boehringer Ingelheim Investigational Site | Clearwater | Florida | — | — |
| 1237.25.10517 Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| 1237.25.10505 Boehringer Ingelheim Investigational Site | Coeur d'Alene | Idaho | — | — |
| 1237.25.10516 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | — | — |
| 1237.25.10509 Boehringer Ingelheim Investigational Site | Livonia | Michigan | — | — |
| 1237.25.10519 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | — | — |
| 1237.25.10503 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1237.25.10518 Boehringer Ingelheim Investigational Site | Columbia | Ohio | — | — |
| 1237.25.10502 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 1237.25.10511 Boehringer Ingelheim Investigational Site | Dublin | Ohio | — | — |
| 1237.25.10514 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| 1237.25.10513 Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| 1237.25.10515 Boehringer Ingelheim Investigational Site | Easley | South Carolina | — | — |
| 1237.25.10506 Boehringer Ingelheim Investigational Site | Greenville | South Carolina | — | — |
| 1237.25.10501 Boehringer Ingelheim Investigational Site | Rock Hill | South Carolina | — | — |
| 1237.25.10508 Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| 1237.25.10520 Boehringer Ingelheim Investigational Site | Killeen | Texas | — | — |
| 1237.25.10510 Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| 1237.25.10521 Boehringer Ingelheim Investigational Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01964352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 24, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01964352 live on ClinicalTrials.gov.